90 related articles for article (PubMed ID: 20005677)
1. In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains.
Park Y; Park SC; Kim JY; Park JO; Seo CH; Nah JW; Hahm KS
Int J Antimicrob Agents; 2010 Feb; 35(2):208-9. PubMed ID: 20005677
[No Abstract] [Full Text] [Related]
2. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial peptides: a new way to treat bacterial infections].
Igaz P
Orv Hetil; 2001 Jan; 142(4):169-71. PubMed ID: 11232153
[TBL] [Abstract][Full Text] [Related]
4. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
Sader HS; Fedler KA; Rennie RP; Stevens S; Jones RN
Antimicrob Agents Chemother; 2004 Aug; 48(8):3112-8. PubMed ID: 15273128
[TBL] [Abstract][Full Text] [Related]
5. The molecular design of a recombinant antimicrobial peptide CP and its in vitro activity.
Niu M; Li X; Wei J; Cao R; Zhou B; Chen P
Protein Expr Purif; 2008 Jan; 57(1):95-100. PubMed ID: 17988890
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification the antimicrobial peptide CM4 in Escherichia coli.
Zhou L; Lin Q; Li B; Li N; Zhang S
Biotechnol Lett; 2009 Mar; 31(3):437-41. PubMed ID: 19037597
[TBL] [Abstract][Full Text] [Related]
7. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
11. Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli.
Tian ZG; Teng D; Yang YL; Luo J; Feng XJ; Fan Y; Zhang F; Wang JH
Appl Microbiol Biotechnol; 2007 May; 75(1):117-24. PubMed ID: 17225098
[TBL] [Abstract][Full Text] [Related]
12. Salt resistance and synergistic effect with vancomycin of alpha-helical antimicrobial peptide P18.
Shin SY; Yang ST; Park EJ; Eom SH; Song WK; Kim Y; Hahm KS; Kim JI
Biochem Biophys Res Commun; 2002 Jan; 290(1):558-62. PubMed ID: 11779208
[TBL] [Abstract][Full Text] [Related]
13. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli.
Lee JH; Minn I; Park CB; Kim SC
Protein Expr Purif; 1998 Feb; 12(1):53-60. PubMed ID: 9473457
[TBL] [Abstract][Full Text] [Related]
14. Synthetic antimicrobial peptidomimetics with therapeutic potential.
Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of the novel peptide CECT7121 against bacteria isolated from mastitic dairy cattle.
Sparo MD; Jones DG; Sánchez Bruni SF
Lett Appl Microbiol; 2009 Feb; 48(2):187-92. PubMed ID: 19141040
[TBL] [Abstract][Full Text] [Related]
16. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
17. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
Yang ST; Shin SY; Hahm KS; Kim JI
Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial preservative effectiveness of natural peptide antibiotics.
Kamysz W; Turecka K
Acta Pol Pharm; 2005; 62(5):341-4. PubMed ID: 16459482
[TBL] [Abstract][Full Text] [Related]
19. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli.
Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK
Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719
[TBL] [Abstract][Full Text] [Related]
20. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria.
Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM
Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
